Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-10-18

Clinical Trial Update: Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts [NA]

View source ↗

Summary

A breast cancer imaging trial evaluating a new ultrasound contrast method to detect abnormal blood flow in breast masses has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Breast Cancer, Breast Abnormalities | NA | Status: WITHDRAWN